Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis. Sellebjerg F, Cadavid D, Steiner D, Villar L M, Reynolds R, Mikol D Ther Adv Neurol Disord. 2016 Jan; 9(1):31-43. PMID: 26788129. Abstract CommentRecommendBookmarkWatch